Literature DB >> 9231573

Recurrent toxic delirium in a patient treated with SSRIs: is old age a risk factor?

I Amir1, M Dano, A Joffe.   

Abstract

We present the case of a 71-year-old female suffering from bipolar affective disorder type 2 and an old lacunar brain infarct who, under the combined treatment of fluoxetine for depression and low dose trazodone for the accompanying insomnia, developed a toxic delirium. The subject presented with mental state changes (confusion and agitation), hyperreflexia, diaphoresis, nausea, vomiting, fever, and a general tonic-clonic seizure which developed soon after an increase in the trazodone dose. One year prior to the above episode, she was hospitalized for a transient episode of agitated confusion while being treated with fluvoxamine for depression, alprazolam and brotazolam for the accompanying anxiety and insomnia. Both episodes subsided spontaneously when treatment was discontinued. This case reports the possible existence of increased vulnerability to hyperserotonergic states in elderly patients suffering from concomitant psychiatric and neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231573

Source DB:  PubMed          Journal:  Isr J Psychiatry Relat Sci        ISSN: 0333-7308            Impact factor:   0.481


  1 in total

1.  Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease.

Authors:  Tsutomu Furuse; Kenji Hashimoto
Journal:  Ann Gen Psychiatry       Date:  2010-01-20       Impact factor: 3.455

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.